Last reviewed: June 17, 2026

Last updated: June 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections deliver glucagon-like peptide-1 (GLP-1) agonist therapy directly into subcutaneous tissue, where the medication absorbs steadily over seven days. Proper injection technique and site selection minimize bruising, lipohypertrophy (fatty tissue buildup), and injection anxiety. Understanding the fundamentals of at-home injection helps patients achieve consistent therapeutic outcomes.

Approved Injection Sites for Semaglutide Administration

Semaglutide injections must enter the subcutaneous layer—the fatty tissue beneath the skin but above muscle. The FDA-approved injection sites include the abdomen (at least two inches away from the navel), the front or outer surface of the thigh, and the back of the upper arm. Each site offers reliable absorption and accessibility for self-injection. The abdomen generally allows for faster medication onset due to greater blood flow to that region.

Rotating injection sites across these three areas prevents lipohypertrophy, a condition where repeated injections into the same spot cause abnormal fat accumulation or atrophy (tissue loss). Patients should use a different site for each weekly injection and avoid injecting within one inch of a previous injection location. Site rotation also reduces localized inflammation and maintains consistent week-to-week absorption rates, which stabilizes appetite suppression and weight loss outcomes.

Step-by-Step Semaglutide Injection Technique

Begin by washing your hands with soap and warm water for at least 20 seconds. Remove the pen or syringe from the refrigerator 15 to 30 minutes before injection to allow it to reach room temperature—cold medication can cause discomfort upon injection. Inspect the solution visually; it should appear clear and colorless. If it looks cloudy, discolored, or contains particles, do not use it and contact your pharmacy.

Pinch the skin at your chosen injection site firmly between your thumb and forefinger to create a tent of subcutaneous tissue. Insert the needle at a 45- to 90-degree angle in one quick, smooth motion—hesitation increases anxiety and potential tissue trauma. Push the plunger or activation button slowly and steadily to allow the medication to disperse evenly through the tissue. Hold the needle in place for three seconds after completing the injection to ensure the full dose has been delivered.

Remove the needle in the same angle at which you inserted it and gently release the pinched skin. Do not massage the injection site, as this can increase bruising and alter absorption. Place the needle in a designated sharps container immediately after use. Small bruises or minor redness typically fade within hours to days; significant swelling or hard lumps may indicate lipohypertrophy and warrant site-selection adjustments.

Creating a Site Rotation Schedule to Prevent Complications

A structured rotation pattern eliminates guesswork and tracks injection history. One effective approach divides each body region (abdomen, thigh, upper arm) into quadrants, allowing patients to inject into a different quadrant each week over a three-week cycle before repeating. For example: Week 1 uses the right abdominal quadrant, Week 2 the left thigh, Week 3 the right upper arm, then the pattern repeats. This system ensures adequate time between injections in the same site while maintaining a memorable routine.

Some patients prefer mapping sites visually by placing dots on a body diagram or using a smartphone app designed for injection tracking. Documentation prevents accidental repeat injections into recently used sites, which cause cumulative tissue irritation. If lipohypertrophy does develop, avoiding that site for 4 to 12 weeks allows inflammation to resolve and fatty tissue to remodel. Consistent site rotation also correlates with better medication adherence because patients report fewer injection-related side effects and greater comfort week to week.

Optimizing Comfort and Minimizing Injection-Related Side Effects

Cold medication causes vasoconstriction and stiffens fatty tissue, increasing injection discomfort. Allowing the semaglutide pen or syringe to warm to room temperature softens the tissue and allows the needle to pass through with less resistance. Some patients find applying a thin layer of unscented lotion to the injection site beforehand reduces friction and localized irritation. Avoid applying lotions containing menthol or other active ingredients, which may interfere with medication absorption.

Needle anxiety is common but manageable through behavioral techniques. Taking slow, deep breaths before injection activates the parasympathetic nervous system and reduces muscle tension at the injection site. Focusing attention on a neutral object or playing quiet music can distract from needle insertion. Using the thinnest available needle gauge reduces tissue trauma—modern pen systems typically employ 29- to 32-gauge needles, which minimize scarring and lipodystrophy. If bruising occurs, applying ice for 10 minutes after injection followed by gentle pressure reduces blood pooling beneath the skin.

Why Personalized Dosing Requires Professional Guidance

Semaglutide dosing is individualized based on a patient's starting weight, metabolic history, tolerance profile, and therapeutic goals. Initial doses are lower than maintenance doses; physicians typically recommend beginning at 0.25 mg weekly and titrating upward by 0.25 mg increments every four weeks, depending on tolerability and response. This gradual approach minimizes gastrointestinal side effects such as nausea, vomiting, and constipation while allowing the body to adapt to GLP-1 pathway activation.

PlexusDx offers compounded semaglutide injections starting at $149 per month across all dose levels—your dose may need to go up, but your price won't. The Precision Peptide Genetic Test ($99 add-on after the first treatment month) analyzes key genetic variants such as GLP1R rs6923761 and FTO rs9939609, which influence individual response to semaglutide and help predict optimal dosing trajectories. Genetic insights into 14 peptide pathways and 150+ clinical biomarkers enable your PlexusDx clinician to customize your protocol for faster, more sustainable weight loss.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide into muscle instead of subcutaneous tissue?

No. Intramuscular injection causes rapid absorption leading to unpredictable blood levels, increased systemic side effects, and loss of the steady seven-day release profile. Semaglutide is formulated for subcutaneous delivery only. Proper needle angle (45–90 degrees) and pinching the skin ensure medication reaches fatty tissue, not muscle.

What should I do if I accidentally inject into the same site twice in one week?

One repeated injection into the same site typically causes minor irritation but no serious harm. Mark that site as unavailable for at least two weeks and resume your rotation pattern with a different location. If repetition becomes frequent, set phone reminders for injection day and time, or use a tracking app to prevent errors.

How does PlexusDx make semaglutide injections more affordable than branded Wegovy?

PlexusDx partners with licensed 503A compounding pharmacies to prepare pharmaceutical-grade semaglutide at a fraction of brand-name cost. Starting at $149 per month with no insurance required, no membership fees, and HSA/FSA eligibility, PlexusDx removes financial barriers to GLP-1 therapy. Your dose may increase, but your price remains flat.

Is bruising after semaglutide injection normal, and when should I worry?

Minor bruising and redness fade within 24 to 72 hours and are common, especially early in treatment. However, persistent bruising, hard lumps, warmth, or pus at the injection site may indicate infection or severe lipohypertrophy—contact your clinician. Ice application post-injection and strict site rotation minimize bruising risk.

How can the Precision Peptide Genetic Test help me inject semaglutide more effectively?

PlexusDx's Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that influence semaglutide response and optimal dose escalation. Genetic insights allow your clinician to predict whether you'll respond best at a standard maintenance dose or require higher doses, personalizing your injection protocol for faster results.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves